Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BUFFALO, N.Y.--(BUSINESS WIRE)--A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute (RPCI) and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational pharmacological therapy that shows promise for treating both solid-tumor cancers and hematologic malignancies. The affiliation will see RPCI providing preclinical research infrastructure and services to fast-track development of Jasco’s lead agent and speed its progression to the clinical-trial phase.
Help employers find you! Check out all the jobs and post your resume.
